GUT FLORA AS A PROVOCATEUR OF AUTOIMMUNE COLITIS
肠道菌群是自身免疫性结肠炎的诱发因素
基本信息
- 批准号:2887495
- 负责人:
- 金额:$ 19.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-05-01 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:T lymphocyte autoimmune disorder bacterial antigens bacterial cytopathogenic effect cell mediated lymphocytolysis test cytokine disease /disorder model enteric bacteria gastrointestinal epithelium inflammatory bowel diseases interleukin 2 intestinal mucosa laboratory mouse mucosal immunity pathologic process tissue /cell culture ulcerative colitis
项目摘要
DESCRIPTION: (Adapted from the applicant's abstract): The goal of this
research proposal is to utilize the Interleukin-2-deficient (IL-2-/-)
mouse as an animal model of ulcerative colitis (UC) to determine the role
commensal gut bacteria play in the pathogenesis of inflammatory bowl
disease (IBD). A perennial hypothesis for the initiation of IBD is that
the host suffers a breakdown in the mechanisms that normally maintain
"oral tolerance" against environmental antigens in the gut such as
commensal bacteria. The cause of this disregulation is obscure, as are
most of the mechanisms that normally operate to maintain
hyporesponsiveness to gut commensal bacteria. The IL-2/- mouse, however,
seems to offer a promising model to probe the possible relationships
between gut bacterial antigens and specific T cells that may initiate
inflammatory bowl lesions. It is known that these mice develop pathogenic
processes in many tissues, including IBD lesions that resemble those seen
in UC patients, and that these are postponed or moderated by maintaining
the mice under specific pathogen-free or germ-free conditions. Using these
mice the PI proposes to determine if antigen recognition of endogenous
microbial flora by mucosal T cells can initiate or maintain IBD.
The guiding hypothesis for these studies is that the inflammatory immune
response and colitis in IL-2-\- mice is a consequence for the loss of
regulation of T cell responses to normal intestinal bacterial flora. IL-2
may, therefore, be required for the generation and\or function of a
regulatory population(s) of mucosal T cells or, be directly involved in
inhibiting the development of inflammatory responses to enteric antigens.
The PI's proposed studies to experimentally test this hypothesis using the
IL-2-\- mice have two specific aims. The first is to identify members of
commensal enteric bacteria that can activate mucosal T cells that initiate
colitis. The second aim is to investigate the nature of the interaction
between colonic epithelial cells and mucosal T cells and how T cells
mediate the epithelial cell injury that is a hallmark feature of colitis.
In particular, the possibility that epithelial cells can regulate mucosal
T cell responses to enteric antigens by functioning as antigen presenting
cells, and that through the production of soluble growth factors mucosal
T cells can influence epithelial cell growth and function will be
investigated. In addition, the ability of pathogenic T cells to cause or
promote tissue injury through the production of toxic or inflammatory
cytokines will also be investigated.
描述:(改编自申请人的摘要):本项目的目标
研究计划是利用白介素 2 缺陷 (IL-2-/-)
小鼠作为溃疡性结肠炎(UC)动物模型的作用确定
共生肠道细菌在炎症碗的发病机制中发挥作用
疾病(炎症性肠病)。 IBD 起始的一个长期假设是
宿主的正常维持机制出现故障
针对肠道环境抗原的“口服耐受性”,例如
共生细菌。这种失控的原因尚不清楚,因为
大多数正常运作的机制是为了维持
对肠道共生细菌的反应低下。然而,IL-2/-小鼠,
似乎提供了一个有前途的模型来探索可能的关系
肠道细菌抗原和可能启动的特定 T 细胞之间
炎症碗病变。众所周知,这些小鼠会产生致病性
许多组织中的过程,包括类似于所见的 IBD 病变
在 UC 患者中,并且这些可以通过维持来推迟或缓和
将小鼠置于特定的无病原体或无菌条件下。使用这些
PI建议确定小鼠内源性抗原识别是否
粘膜 T 细胞的微生物菌群可以引发或维持 IBD。
这些研究的指导性假设是炎症免疫
IL-2-\- 小鼠的反应和结肠炎是丧失
调节 T 细胞对正常肠道细菌菌群的反应。白细胞介素2
因此,可能需要一个
粘膜 T 细胞的调节群体,或直接参与
抑制肠道抗原炎症反应的发展。
PI 提出的研究使用以下方法通过实验检验这一假设:
IL-2-\- 小鼠有两个具体目标。首先是确定成员
肠道共生细菌可以激活粘膜 T 细胞,从而启动
结肠炎。第二个目标是研究相互作用的本质
结肠上皮细胞和粘膜 T 细胞之间以及 T 细胞如何
介导上皮细胞损伤,这是结肠炎的标志性特征。
特别是,上皮细胞可以调节粘膜的可能性
T 细胞通过发挥抗原呈递作用对肠抗原作出反应
细胞,并通过粘膜产生可溶性生长因子
T细胞可以影响上皮细胞的生长和功能
调查了。此外,致病性 T 细胞能够引起或
通过产生毒性或炎症促进组织损伤
细胞因子也将被研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter J Felsburg其他文献
Peter J Felsburg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter J Felsburg', 18)}}的其他基金
X-LINKED SEVERE COMBINED IMMUNODEFICIENCY IN THE DOG
狗的 X 连锁严重联合免疫缺陷病
- 批准号:
7391952 - 财政年份:2006
- 资助金额:
$ 19.53万 - 项目类别:
X-LINKED SEVERE COMBINED IMMUNODEFICIENCY IN THE DOG
X连锁狗的严重联合免疫缺陷病
- 批准号:
7153989 - 财政年份:2005
- 资助金额:
$ 19.53万 - 项目类别:
X-LINKED SEVERE COMBINED IMMUNODEFICIENCY IN THE DOG
X连锁狗的严重联合免疫缺陷病
- 批准号:
7011847 - 财政年份:2004
- 资助金额:
$ 19.53万 - 项目类别:
相似海外基金
Autoimmune disorder in hereditary angioedema
遗传性血管性水肿中的自身免疫性疾病
- 批准号:
26460654 - 财政年份:2014
- 资助金额:
$ 19.53万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanisms of lymphocyte transmigration across the blood-brain barrier using an in vitro model that mimics blood flow and simulates inflammatory conditions as observed in the most frequent autoimmune disorder of the central nervous system, multiple sclero
使用体外模型模拟血流并模拟在中枢神经系统最常见的自身免疫性疾病多发性硬化症中观察到的炎症状况,从而研究淋巴细胞跨血脑屏障的迁移机制
- 批准号:
235301825 - 财政年份:2013
- 资助金额:
$ 19.53万 - 项目类别:
Research Fellowships
The challenge for the development of therapy for autoimmune disorder by the establishment of artificial thymic medullary organ
人工胸腺髓质器官的建立对自身免疫性疾病治疗发展的挑战
- 批准号:
23659241 - 财政年份:2011
- 资助金额:
$ 19.53万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research














{{item.name}}会员




